我的生活+的主要目标之一是帮助人们预防新的HIV和其他STI，丙型肝炎和结核病病历的产生。

该应用程序有助于建立医生和HIV感染者之间的匿名沟通。它可以让您创建简单易行的服药时间表，并设置隐藏和个性化的提醒。

全部新闻 / 三月 2022

归档

✕

11 三月 2022

1782

Link shown between PrEP use and loss of bone density

Link shown between PrEP use and loss of bone density

It has been known for some time that use of Truvada, and generic versions of tenofovir disoproxil fumarate/emtricitabine (TDF/FTC), has been associated with the loss of bone density in people living with HIV. But there has been a lack of data on how the drug combination ...

11 三月 2022

1743

How does the microflora of male genitalia system affect HIV infection?

How does the microflora of male genitalia system affect HIV infection?

Scientists at the George Washington University in the United States are launching a new study to determine what role the microbiome (microflora) of the urogenital tract might play in HIV infection. The purpose of the five-year trial is to find new solutions aimed at reducing ...

11 三月 2022

1461

Integrase inhibitors connected to a higher risk of hypertensions in people living with HIV

Integrase inhibitors connected to a higher risk of hypertensions in people living with HIV

The RESPOND study, involving more than 30,000 people living with HIV from 17 cohorts, has confirmed the link between the link of integrase inhibitors (INSTI) and the incidence of hypertension. The research results have been presented by our parters at the European AIDS Treatment ...

11 三月 2022

1926

FDA denies Lenacapavir approval due to issues with glass vials

FDA denies Lenacapavir approval due to issues with glass vials

The Food and Drug Administration (FDA) has refused to approve an antiretroviral HIV treatment from Gilead Sciences due to concerns about the glass vials used to store the treatment, reports Reuters, citing Gilead’s statement. In a full response, the FDA highlighted issues ...

1 2